Latest filing published 21 Sept 2021 for Alpine Immune Sciences, INC., €3.2M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Alpine ImmunoSciences, L.P.: trading record in brief
Alpine ImmunoSciences, L.P. discloses dealings in Alpine Immune Sciences, Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 18 January 2019 and the latest from 17 September 2021.
Market trades split into 1 purchase (€900k) and 1 sale (€3.2M). Sales outweigh purchases by €2.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2021 to date brings no purchases and 1 sale.
Most recently, on 21 September 2021, the filings show an open-market sale worth €3.2M in Alpine Immune Sciences, Inc. The most recent open-market purchase was published on 22 January 2019, 2,848 days ago. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alpine ImmunoSciences, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 400,000 shares@ US$9.40100.0% of flowCommon StockSEC:0001626199-21-000116:0
- 993,801 shares0Common StockSEC:0000899243-20-034853:0
- 190,875 shares@ US$5.3722.0% of flowCommon StockSEC:0000899243-19-001663:0Canonical exit: 18 Apr 2019 (T+90)
3 of 3 declarations
